Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Shamik Parikh, MD
Humacyte, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitätsklinikmn Erlangen, Gefäßchirurgie - Chirurgisches Zentrum
Erlangen, Bavaria, Germany
- Universitätsklinikum Frankfurt Klinik Für Gefäß- Und Endovascular-Chirurgie
Frankfurt am Main, Hesse, Germany
- Rambam Health Care Campus
Haifa, Haifa District, Israel
- the Chaim Sheba Medical Center
Ramat Gan, Tel Aviv, Israel
- Hillel Jaffe Medical Center
Hadera, Israel
- Sharee Zedek Medical Center
Jerusalem, Israel
- Yitzhak Shamir Medical Center - Assaf Harofeh
Tzrifin, Israel
- Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego Im. Karola Marcinkowskiego
Poznan, Poland
- Samodzielny Publiczyn Centralny Szpital Klinziczny W Warszawie - Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego
Warsaw, Poland
- Wojewódzki Szpital Specjalistyczny We Wrocławiu
Wroclaw, Poland
- Grupo de Estudos Vasculares
Porto, Portugal
- Leicester General Hospital
Leicester, East Midlands/ Leicestershire, United Kingdom
- Guy´s Hospital, Kings´college London
London, Greater London, United Kingdom
- Queen Elizabeth Hospital Birmingham
Birmingham, West Midlands, United Kingdom
- Queen Elizabeth University Hospital Glasgow
Glasgow, United Kingdom
- Leeds General Infirmary
Leeds, United Kingdom
- Arizona Kidney Disease and Hypertension Center (akdhc)
Phoenix, Arizona, United States
- Carondelet St. Mary'S Hospital
Tucson, Arizona, United States
- General Surgery and Vascular Access
Fresno, California, United States
- Ladenheim Dialysis Access Center
Fresno, California, United States
- University of California Irvine (uci) Medical Center
Irvine, California, United States
- Va Long Beach Healthcare System
Long Beach, California, United States
- Va Sacramento Medical Center
Mather, California, United States
- Balboa Nephrology
San Diego, California, United States
- University of South Florida
Tampa, Florida, United States
- Southwest Vascular Access Center
Alsip, Illinois, United States
- University of Maryland Medical Center
Baltimore, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Michigan Cardiovascular Institute
Flint, Michigan, United States
- Greenwood Leflore Hospital
Greenwood, Mississippi, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Rutgers-New Jersey Medical School
Newark, New Jersey, United States
- the Cardiovascular Care Group
Westfield, New Jersey, United States
- Duke University Hospital
Durham, North Carolina, United States
- Kaiser Permanente
Portland, Oregon, United States
- Medical University of South Carolina (musc)
Orangeburg, South Carolina, United States
- Baylor Scott and White Research Institute
Dallas, Texas, United States
- University of Wisconsin
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 May 2016
- Primary completion
- 31 May 2019
- Completion
- 30 Sept 2023
- Last update posted
- 19 Aug 2026
- Registered enrollment
- 355
- Registry id
- NCT02644941
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.